FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3007484432> ?p ?o ?g. }

• W3007484432 endingPage "31" @default.
• W3007484432 startingPage "23" @default.
• W3007484432 abstract "ObjectiveHealth-related quality of life (HRQoL) is one of the most important patient-relevant study end-points for the direct measurement of the benefit of cancer drugs. Therefore, our aim is to detect cancer indications with no published information on HRQoL at the time of European Medicines Agency (EMA) approval and monitor any reported HRQoL evidence updates after at least three years of follow-up.MethodsWe included all cancer indications that were approved by the EMA between January 2009 and October 2015. Our main sources of information were the EMA website, clinicaltrials.gov and a systematic literature search in PubMed. Information on HRQoL outcomes was extracted alongside evidence on median overall survival.ResultsIn total, we identified 110 indications, of which more than half (n = 58, 53%) were lacking available information on HRQoL assessments at the time of EMA approval. After a monitoring period of at least three years, 24 updates were identified, resulting in 34 (31%) therapies where information on HRQoL was still not available. For the 76 therapies with reported information on HRQoL, cancer-specific instruments were mostly used (n = 49/76). Regarding cumulative evidence on median overall survival and HRQoL, 33 (n = 33/110, 30%) as well as 15 (n = 15/110, 14%) cancer drugs were lacking information on both study end-points at the time of approval and after monitoring, respectively.ConclusionOur results demonstrate that there is an urgent need of routine re-evaluation of reimbursed cancer drugs with initially missing information on major outcomes. Standardisation of the typology and quality of HRQoL assessments need to be improved to allow better comparability of results." @default.
• W3007484432 created "2020-03-06" @default.
• W3007484432 creator A5013647089 @default.
• W3007484432 creator A5022407386 @default.
• W3007484432 creator A5031004602 @default.
• W3007484432 creator A5064339323 @default.
• W3007484432 creator A5076187964 @default.
• W3007484432 date "2020-04-01" @default.
• W3007484432 modified "2023-09-23" @default.
• W3007484432 title "Publicly accessible evidence of health-related quality of life benefits associated with cancer drugs approved by the European Medicines Agency between 2009 and 2015" @default.
• W3007484432 cites W1937020882 @default.
• W3007484432 cites W1971159432 @default.
• W3007484432 cites W1990681363 @default.
• W3007484432 cites W2011797387 @default.
• W3007484432 cites W2037630794 @default.
• W3007484432 cites W2055022993 @default.
• W3007484432 cites W2080324444 @default.
• W3007484432 cites W2105258029 @default.
• W3007484432 cites W2108881270 @default.
• W3007484432 cites W2123610405 @default.
• W3007484432 cites W2134119471 @default.
• W3007484432 cites W2136919572 @default.
• W3007484432 cites W2151023863 @default.
• W3007484432 cites W2153836018 @default.
• W3007484432 cites W2155562610 @default.
• W3007484432 cites W2167571044 @default.
• W3007484432 cites W2279074305 @default.
• W3007484432 cites W2586144993 @default.
• W3007484432 cites W2606058235 @default.
• W3007484432 cites W2606179569 @default.
• W3007484432 cites W2606845361 @default.
• W3007484432 cites W2620771841 @default.
• W3007484432 cites W2621250710 @default.
• W3007484432 cites W2764112934 @default.
• W3007484432 cites W2884459417 @default.
• W3007484432 cites W2897807341 @default.
• W3007484432 cites W2911634114 @default.
• W3007484432 cites W2922636999 @default.
• W3007484432 cites W2954875571 @default.
• W3007484432 doi "https://doi.org/10.1016/j.ejca.2020.01.020" @default.
• W3007484432 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32120272" @default.
• W3007484432 hasPublicationYear "2020" @default.
• W3007484432 type Work @default.
• W3007484432 sameAs 3007484432 @default.
• W3007484432 citedByCount "7" @default.
• W3007484432 countsByYear W30074844322021 @default.
• W3007484432 countsByYear W30074844322022 @default.
• W3007484432 countsByYear W30074844322023 @default.
• W3007484432 crossrefType "journal-article" @default.
• W3007484432 hasAuthorship W3007484432A5013647089 @default.
• W3007484432 hasAuthorship W3007484432A5022407386 @default.
• W3007484432 hasAuthorship W3007484432A5031004602 @default.
• W3007484432 hasAuthorship W3007484432A5064339323 @default.
• W3007484432 hasAuthorship W3007484432A5076187964 @default.
• W3007484432 hasBestOaLocation W30074844321 @default.
• W3007484432 hasConcept C108170787 @default.
• W3007484432 hasConcept C111472728 @default.
• W3007484432 hasConcept C121608353 @default.
• W3007484432 hasConcept C126322002 @default.
• W3007484432 hasConcept C138885662 @default.
• W3007484432 hasConcept C159110408 @default.
• W3007484432 hasConcept C166957645 @default.
• W3007484432 hasConcept C17744445 @default.
• W3007484432 hasConcept C199539241 @default.
• W3007484432 hasConcept C2778527826 @default.
• W3007484432 hasConcept C2779473830 @default.
• W3007484432 hasConcept C2779951463 @default.
• W3007484432 hasConcept C3020167199 @default.
• W3007484432 hasConcept C512399662 @default.
• W3007484432 hasConcept C71924100 @default.
• W3007484432 hasConcept C75795011 @default.
• W3007484432 hasConcept C95457728 @default.
• W3007484432 hasConceptScore W3007484432C108170787 @default.
• W3007484432 hasConceptScore W3007484432C111472728 @default.
• W3007484432 hasConceptScore W3007484432C121608353 @default.
• W3007484432 hasConceptScore W3007484432C126322002 @default.
• W3007484432 hasConceptScore W3007484432C138885662 @default.
• W3007484432 hasConceptScore W3007484432C159110408 @default.
• W3007484432 hasConceptScore W3007484432C166957645 @default.
• W3007484432 hasConceptScore W3007484432C17744445 @default.
• W3007484432 hasConceptScore W3007484432C199539241 @default.
• W3007484432 hasConceptScore W3007484432C2778527826 @default.
• W3007484432 hasConceptScore W3007484432C2779473830 @default.
• W3007484432 hasConceptScore W3007484432C2779951463 @default.
• W3007484432 hasConceptScore W3007484432C3020167199 @default.
• W3007484432 hasConceptScore W3007484432C512399662 @default.
• W3007484432 hasConceptScore W3007484432C71924100 @default.
• W3007484432 hasConceptScore W3007484432C75795011 @default.
• W3007484432 hasConceptScore W3007484432C95457728 @default.
• W3007484432 hasLocation W30074844321 @default.
• W3007484432 hasLocation W30074844322 @default.
• W3007484432 hasOpenAccess W3007484432 @default.
• W3007484432 hasPrimaryLocation W30074844321 @default.
• W3007484432 hasRelatedWork W2113172797 @default.
• W3007484432 hasRelatedWork W2127383492 @default.
• W3007484432 hasRelatedWork W2154326194 @default.
• W3007484432 hasRelatedWork W2158844191 @default.
• W3007484432 hasRelatedWork W2510892602 @default.

• next